Hsuan-Ni Lin

Title: Hsuan-Ni Lin: Innovator in Gene Therapies for Lysosomal Disorders

Introduction

Hsuan-Ni Lin is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of gene therapies, particularly in addressing lysosomal disorders. His innovative work has the potential to impact the treatment of various diseases, including fronto-temporal dementia (FTD).

Latest Patents

Hsuan-Ni Lin holds a patent related to gene therapies for lysosomal disorders. The patent discloses compositions and methods for treating diseases associated with aberrant lysosomal function. This includes the development of expression constructs comprising a transgene encoding progranulin or a portion thereof. The methods outlined in the patent provide a means of treating FTD by administering these expression constructs to subjects in need.

Career Highlights

Hsuan-Ni Lin is currently associated with Prevail Therapeutics, Inc., where he continues to advance his research in gene therapies. His work is crucial in the ongoing efforts to develop effective treatments for lysosomal disorders.

Collaborations

Hsuan-Ni Lin collaborates with notable colleagues, including Asa Abeliovich and Laura Heckman. Their combined expertise contributes to the innovative research being conducted at Prevail Therapeutics.

Conclusion

Hsuan-Ni Lin's contributions to gene therapies for lysosomal disorders exemplify the impact of innovative research in medicine. His work holds promise for improving treatment options for patients suffering from these challenging conditions.